Primary Biliary Cirrhosis and Hemolytic Anemia Confusing Serum Bilirubin Levels by M Brackstone, Cameron N Ghent

“…Hemolysis is observed in more than 50% of patients with cirrhosis. However, there has been little documention of the association of primary biliary cirrhosis with autoimmune hemolytic anemia. …”
Get full text

Characteristics of primary biliary cirrhosis in British Columbia's First Nations population by Laura Arbour, Rosemarie Rupps, Leigh Field, Paul Ross, Anders Erikson, Harvey Henderson, Warren Hill, Eric M Yoshida

“…Primary biliary cirrhosis (PBC) is a rare, autoimmune liver disorder characterized by progressive destruction of intrahepatic bile ducts, that results in portal inflammation, scarring, cirrhosis and, eventually, liver failure. …”
Get full text

Machine learning-based plasma metabolomics for improved cirrhosis risk stratification by Jingru Song, Ziwei Gao, Liqun Lai, Jie Zhang, Binbin Liu, Yi Sang, Siqi Chen, Jiachen Qi, Yujun Zhang, Huang Kai, Wei Ye

Subjects: “…Cirrhosis…”
Get full text

Management of Anticoagulation for Portal Vein Thrombosis in Individuals with Cirrhosis: A Systematic Review by Geneviève Huard, Marc Bilodeau

“…Non-neoplastic portal vein thrombosis (PVT) is an increasingly recognized complication of liver cirrhosis. It is often diagnosed fortuitously and can be either partial or complete. …”
Get full text

The impact of bacterial overgrowth syndrome and systemic inflammation on abdominal hemodynamics in liver cirrhosis by R. V. Maslennikov, M. A. Tatarkina, M. V. Mayevskaya, Ch. S. Pavlov, M. S. Zharkova, V. T. Ivashkin

Get full text

Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury by Justin M. Belcher, Arun J. Sanyal, Guadalupe Garcia-Tsao, Naheed Ansari, Steven G. Coca, Michael G. Shlipak, Chirag R. Parikh

“…Acute kidney injury (AKI) is a common and severe complication in patients with cirrhosis. Progression of AKI to a higher stage associates with increased mortality. …”
Get full text

Results of non-interventional observational study of ursodeoxycholic acid in primary biliary cirrhosis by Yelena N. Shirokova, Anna F. Sheptulina

“…To estimate clinical efficacy and safety of ursodeoxycholic acid («Livodexa®») in a dose of 15 mg/kg/day for 3 months in the treatment of primary biliary cirrhosis (PBC) of the I to III stage. Material and methods. …”
Get full text

Structure and Functions of Human Serum Albumin in Normal Conditions and in Patients with Liver Cirrhosis by A. A. Turkina, M. V. Mayevskaya, M. S. Zharkova, V. T. Ivashkin

Subjects: Get full text

Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States by Abhijeet Waghray, Nisheet Waghray, Hicham Khallafi, K. V. Narayanan Menon

“…Prior studies assessing vaccination rates in patients with cirrhosis have specific limitations and to date no study has provided a comprehensive evaluation of vaccination rates in patients with cirrhosis in the United States. …”
Get full text

Quantifying Liver Cirrhosis by Extracting Significant Features from MRI T2 Image by Ming-Hong Hshiao, Po-Chou Chen, Jo-Chi Jao, Yung-Hui Huang, Chen-Chang Lee, Shih-Yu Chao, Li-Wei Lin, Tai-Been Chen

“…Most patients with liver cirrhosis must undergo a series of clinical examinations, including ultrasound imaging, liver biopsy, and blood tests. …”
Get full text

Survival and Disease Progression in Older Adult Patients With Cirrhosis: A Retrospective Study by Khaled Al-Smadi, Ammar Qureshi, Michelle Buitrago, Besher Ashouri, Zeid Kayali

“…A prospective study is needed to further investigate the effect of age and obesity on survival and disease progression in older adult patients with cirrhosis.…”
Get full text

A Comprehensive Review of Portosystemic Collaterals in Cirrhosis: Historical Aspects, Anatomy, and Classifications by Cyriac Abby Philips, Ankur Arora, Rajesh Shetty, Vivek Kasana

“…Portosystemic collateral formation in cirrhosis plays an important part in events that define the natural history in affected patients. …”
Get full text

Unexplained Findings of Kayser-Fleischer-Like Rings in a Patient with Cryptogenic Cirrhosis by Mahreema Jawairia, Miral Subhani, Ghulam Siddiqui, Apsara Prasad, Ghulamullah Shahzad, Kaleem Rizvon, Paul Mustacchia

“…Cryptogenic cirrhosis (CC) is defined as cirrhosis occurring in an individual without an identifiable cause of liver disease, such as excessive alcohol consumption, viral hepatitis infection, hemochromatosis, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, chronic intake of medications that could induce cirrhosis, alpha-1-antitrypsin deficiency, Wilson’s disease, or any other rare cause of cirrhosis according to the clinical context. …”
Get full text

Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation by P. D. Bessonov, I. V. Borzunov, E. N. Bessonova

“…Esсheriсhia сoli и Klebsiella pneumoniae were the most common infectious agents in liver cirrhosis patients. Frequency of urinary tract infections was higher in those with severe liver cirrhosis complications (in past history as well) such as hepatic encephalopathy, ascites, spontaneous bacterial peritonitis. …”
Get full text

Celiac Disease Assocaited with Primary Biliary Cirrhosis in a Coast Salish Native by Hugh J Freeman

“…Clinical and pathological features of primary biliary cirrhosis were also present, along with a familial history of insulin-dependent diabetes. …”
Get full text

Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver Cirrhosis by Marta Gonzalez Rozas, Lidia Hernanz Roman, Diego Gonzalez Gonzalez, José Luis Pérez-Castrillón

“…We present the case of a young patient with liver cirrhosis of unknown aetiology that was finally attributed to panhypopituitarism.…”
Get full text

Primary biliary cirrhosis: clinical and laboratory criteria of diagnostics and up-to-date treatment by L. Yu. Il’chenko, V. I. Reshetn’yak

Subjects: “…primary biliary cirrhosis…”
Get full text

Time to Make the Change from ‘Primary Biliary Cirrhosis’ to ‘Primary Biliary Cholangitis’ by Angela C Cheung, Aldo Montano-Loza, Mark Swain, Catherine Vincent, Eberhard Renner, Morris Sherman, Harry LA Janssen, Andrew L Mason

Get full text

Triple antiviral therapy in patient with liver cirrhosis: complications and options of pharmacological treatment by M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin

Subjects: Get full text

Sympathetic Nervous Regulation in Patients with Cirrhosis: Pathogenesis of Fluid Retention and Formation of Ascites by Jens H Henriksen, Helmer Ring-Larsen, Niels Juel Christensen

“…Increased circulating noradrenaline in patients with cirrhosis is due to enhanced sympathetic nervous activity and is not merely the result of decreased clearance of catecholamines. …”
Get full text